NOC · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $41.95B | $41.03B | $39.29B | $36.60B | $35.67B | $36.80B | $33.84B | $30.09B |
| Research & Development | $1.10B | $1.10B | $1.20B | $1.20B | $1.10B | $1.10B | $953.00M | $764.00M |
| Selling, General & Administrative | $4.03B | $3.99B | $4.01B | $3.87B | $3.60B | $3.41B | $3.29B | $3.01B |
| Operating Expenses | $37.67B | $36.66B | $36.75B | $33.00B | $32.00B | $32.73B | $29.87B | — |
| Operating Income | $4.51B | $4.37B | $2.54B | $3.60B | $5.65B | $4.07B | $3.97B | $3.78B |
| Other Income / (Expense) | $154.00M | $168.00M | $246.00M | $4.00M | $19.00M | $92.00M | $107.00M | $130.00M |
| Income Before Taxes | $5.07B | $5.02B | $2.35B | $5.84B | $8.94B | $3.73B | $2.55B | $3.74B |
| Provision for Income Taxes | $886.00M | $842.00M | $290.00M | $940.00M | $1.93B | $539.00M | $300.00M | $513.00M |
| Net Income | $4.18B | $4.17B | $2.06B | $4.90B | $7.00B | $3.19B | $2.25B | $3.23B |
| Basic EPS | $29.14 | $28.39 | $13.57 | $31.61 | $43.70 | $19.08 | $13.28 | $18.59 |
| Diluted EPS | $29.08 | $28.34 | $13.53 | $31.47 | $43.54 | $19.03 | $13.22 | $18.49 |
| Basic Shares Outstanding | 143.50M | 147.00M | 151.50M | 154.90M | 160.30M | 167.10M | 169.30M | 173.70M |
| Diluted Shares Outstanding | 143.80M | 147.30M | 152.00M | 155.60M | 160.90M | 167.60M | 170.00M | 174.60M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $28.97 | $28.82 | $29.20 | 6 | ↑6 ↓0 |
| Dec 2027 | $30.44 | $29.55 | $31.84 | 8 | ↑6 ↓1 |
| Dec 2028 | $32.67 | $32.15 | $34.15 | 4 | ↑3 ↓0 |
| Dec 2029 | $34.93 | $34.93 | $34.93 | 2 | ↑2 ↓0 |